chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 65.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19, COVID-19 pneumonia, Chest X-ray abnormal, Computerised tomogram thorax abnormal, Cough
Clinical narrative: Narrative:  Admission Date: Aug 22,2021 Discharge Date: Oct 26,2021 Condition of patient at discharge: Stable Disposition of Patient at Discharge: Acute Rehab Primary Diagnosis during Admission/Treatment: Acute respiratory failure in the context of COVID infection 64 YO MALE w/ Asthma-COPD overlap syndrome (ACOS), restrictive lung disease (FEV1 40%, TLC 50%), hx of ABPA, hx of DVT/PE (remote, not on anticoagulation), HTN, HLD, PTSD came to the Emergency Room on 8/22/2021 for SOB and syncope in the setting of covid+, despite full vaccination with Pfizer Covid vaccine on 5/20/2021 and 6/10/2021. His wife then was diagnosed w/ covid approx 1 week prior and he tested positive on August 16th. He was feeling well until the last 3 days when he developed progressive dyspnea, cough w/ yellow sputum, and nausea. He was in his garage when he began to feel dizzy and passed out. His wife found him there, thought to be about 15 minutes later. He stated she did not notice any unusual jerking activity or incontinence. In the Emergency Dept, he was hypoxic requiring HFNC 45L/50%, tachycardic to 120, w/ cough & wheeze. CXR and CT PE indicative of COVID pneumonia. The patient was admitted to the Medical ICU from 8/22/21 to 10/14/21. He was intubated on 8/26/21. Unfortunately, he was out of the window for remdesivir and was not a candidate for baracitinib or monoclonal antibody due to concerns for infection. Patient had a prolonged hospital course while intubated complicated by vent dysynchrony, septic shock, and acute renal failure requiring tablo. He had a trach placed on 9/29/21 and has been off all ventilator support since 10/10/21. Tablo was stopped 9/17 and his renal function has since improved with just PRN Lasix (Serum Creatinine from 10/13 is 0.61). On 10/13, patient was transitioned to a cuffless trach and capping trials were started on 10/14. As far as antimicrobials, patient is currently on nystatin for oral thrush (10/13-preset) and cefepime for pseudomonas and klebsiella PNA (10/3-10/17). As far as feeding, patient passed a barium swallow study on 10/12. He still has NG tube feeds to supplement PO feeds. Once out of the ICU, the patient was stable and required minimal intervention. The patient completed his cefepime course with no evidence of reinfection. While on the ward, follow up chest x-rays were unchanged. White count similarly was within normal limits and stable. The patient was decanulated within the first 48 hours and has tolerated 2-3 liters of oxygen via nasal cannula well. He was dishcharge to an acute rehab facility on 10/26/21.
Age: 65.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Dizziness, Dyspnoea, Emphysema, Endotracheal intubation, Gastrointestinal tube insertion
Clinical narrative: Narrative:  Admission Date: Aug 22,2021 Discharge Date: Oct 26,2021 Condition of patient at discharge: Stable Disposition of Patient at Discharge: Acute Rehab Primary Diagnosis during Admission/Treatment: Acute respiratory failure in the context of COVID infection 64 YO MALE w/ Asthma-COPD overlap syndrome (ACOS), restrictive lung disease (FEV1 40%, TLC 50%), hx of ABPA, hx of DVT/PE (remote, not on anticoagulation), HTN, HLD, PTSD came to the Emergency Room on 8/22/2021 for SOB and syncope in the setting of covid+, despite full vaccination with Pfizer Covid vaccine on 5/20/2021 and 6/10/2021. His wife then was diagnosed w/ covid approx 1 week prior and he tested positive on August 16th. He was feeling well until the last 3 days when he developed progressive dyspnea, cough w/ yellow sputum, and nausea. He was in his garage when he began to feel dizzy and passed out. His wife found him there, thought to be about 15 minutes later. He stated she did not notice any unusual jerking activity or incontinence. In the Emergency Dept, he was hypoxic requiring HFNC 45L/50%, tachycardic to 120, w/ cough & wheeze. CXR and CT PE indicative of COVID pneumonia. The patient was admitted to the Medical ICU from 8/22/21 to 10/14/21. He was intubated on 8/26/21. Unfortunately, he was out of the window for remdesivir and was not a candidate for baracitinib or monoclonal antibody due to concerns for infection. Patient had a prolonged hospital course while intubated complicated by vent dysynchrony, septic shock, and acute renal failure requiring tablo. He had a trach placed on 9/29/21 and has been off all ventilator support since 10/10/21. Tablo was stopped 9/17 and his renal function has since improved with just PRN Lasix (Serum Creatinine from 10/13 is 0.61). On 10/13, patient was transitioned to a cuffless trach and capping trials were started on 10/14. As far as antimicrobials, patient is currently on nystatin for oral thrush (10/13-preset) and cefepime for pseudomonas and klebsiella PNA (10/3-10/17). As far as feeding, patient passed a barium swallow study on 10/12. He still has NG tube feeds to supplement PO feeds. Once out of the ICU, the patient was stable and required minimal intervention. The patient completed his cefepime course with no evidence of reinfection. While on the ward, follow up chest x-rays were unchanged. White count similarly was within normal limits and stable. The patient was decanulated within the first 48 hours and has tolerated 2-3 liters of oxygen via nasal cannula well. He was dishcharge to an acute rehab facility on 10/26/21.
Age: 65.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Hypoxia, Intensive care, Loss of consciousness, Lung opacity, Nausea
Clinical narrative: Narrative:  Admission Date: Aug 22,2021 Discharge Date: Oct 26,2021 Condition of patient at discharge: Stable Disposition of Patient at Discharge: Acute Rehab Primary Diagnosis during Admission/Treatment: Acute respiratory failure in the context of COVID infection 64 YO MALE w/ Asthma-COPD overlap syndrome (ACOS), restrictive lung disease (FEV1 40%, TLC 50%), hx of ABPA, hx of DVT/PE (remote, not on anticoagulation), HTN, HLD, PTSD came to the Emergency Room on 8/22/2021 for SOB and syncope in the setting of covid+, despite full vaccination with Pfizer Covid vaccine on 5/20/2021 and 6/10/2021. His wife then was diagnosed w/ covid approx 1 week prior and he tested positive on August 16th. He was feeling well until the last 3 days when he developed progressive dyspnea, cough w/ yellow sputum, and nausea. He was in his garage when he began to feel dizzy and passed out. His wife found him there, thought to be about 15 minutes later. He stated she did not notice any unusual jerking activity or incontinence. In the Emergency Dept, he was hypoxic requiring HFNC 45L/50%, tachycardic to 120, w/ cough & wheeze. CXR and CT PE indicative of COVID pneumonia. The patient was admitted to the Medical ICU from 8/22/21 to 10/14/21. He was intubated on 8/26/21. Unfortunately, he was out of the window for remdesivir and was not a candidate for baracitinib or monoclonal antibody due to concerns for infection. Patient had a prolonged hospital course while intubated complicated by vent dysynchrony, septic shock, and acute renal failure requiring tablo. He had a trach placed on 9/29/21 and has been off all ventilator support since 10/10/21. Tablo was stopped 9/17 and his renal function has since improved with just PRN Lasix (Serum Creatinine from 10/13 is 0.61). On 10/13, patient was transitioned to a cuffless trach and capping trials were started on 10/14. As far as antimicrobials, patient is currently on nystatin for oral thrush (10/13-preset) and cefepime for pseudomonas and klebsiella PNA (10/3-10/17). As far as feeding, patient passed a barium swallow study on 10/12. He still has NG tube feeds to supplement PO feeds. Once out of the ICU, the patient was stable and required minimal intervention. The patient completed his cefepime course with no evidence of reinfection. While on the ward, follow up chest x-rays were unchanged. White count similarly was within normal limits and stable. The patient was decanulated within the first 48 hours and has tolerated 2-3 liters of oxygen via nasal cannula well. He was dishcharge to an acute rehab facility on 10/26/21.
Age: 65.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Oral candidiasis, Pneumonia klebsiella, Pseudomonas infection, SARS-CoV-2 test positive, Septic shock
Clinical narrative: Narrative:  Admission Date: Aug 22,2021 Discharge Date: Oct 26,2021 Condition of patient at discharge: Stable Disposition of Patient at Discharge: Acute Rehab Primary Diagnosis during Admission/Treatment: Acute respiratory failure in the context of COVID infection 64 YO MALE w/ Asthma-COPD overlap syndrome (ACOS), restrictive lung disease (FEV1 40%, TLC 50%), hx of ABPA, hx of DVT/PE (remote, not on anticoagulation), HTN, HLD, PTSD came to the Emergency Room on 8/22/2021 for SOB and syncope in the setting of covid+, despite full vaccination with Pfizer Covid vaccine on 5/20/2021 and 6/10/2021. His wife then was diagnosed w/ covid approx 1 week prior and he tested positive on August 16th. He was feeling well until the last 3 days when he developed progressive dyspnea, cough w/ yellow sputum, and nausea. He was in his garage when he began to feel dizzy and passed out. His wife found him there, thought to be about 15 minutes later. He stated she did not notice any unusual jerking activity or incontinence. In the Emergency Dept, he was hypoxic requiring HFNC 45L/50%, tachycardic to 120, w/ cough & wheeze. CXR and CT PE indicative of COVID pneumonia. The patient was admitted to the Medical ICU from 8/22/21 to 10/14/21. He was intubated on 8/26/21. Unfortunately, he was out of the window for remdesivir and was not a candidate for baracitinib or monoclonal antibody due to concerns for infection. Patient had a prolonged hospital course while intubated complicated by vent dysynchrony, septic shock, and acute renal failure requiring tablo. He had a trach placed on 9/29/21 and has been off all ventilator support since 10/10/21. Tablo was stopped 9/17 and his renal function has since improved with just PRN Lasix (Serum Creatinine from 10/13 is 0.61). On 10/13, patient was transitioned to a cuffless trach and capping trials were started on 10/14. As far as antimicrobials, patient is currently on nystatin for oral thrush (10/13-preset) and cefepime for pseudomonas and klebsiella PNA (10/3-10/17). As far as feeding, patient passed a barium swallow study on 10/12. He still has NG tube feeds to supplement PO feeds. Once out of the ICU, the patient was stable and required minimal intervention. The patient completed his cefepime course with no evidence of reinfection. While on the ward, follow up chest x-rays were unchanged. White count similarly was within normal limits and stable. The patient was decanulated within the first 48 hours and has tolerated 2-3 liters of oxygen via nasal cannula well. He was dishcharge to an acute rehab facility on 10/26/21.
Age: 65.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Sputum discoloured, Syncope, Tachycardia, Tracheostomy, Ventricular dyssynchrony
Clinical narrative: Narrative:  Admission Date: Aug 22,2021 Discharge Date: Oct 26,2021 Condition of patient at discharge: Stable Disposition of Patient at Discharge: Acute Rehab Primary Diagnosis during Admission/Treatment: Acute respiratory failure in the context of COVID infection 64 YO MALE w/ Asthma-COPD overlap syndrome (ACOS), restrictive lung disease (FEV1 40%, TLC 50%), hx of ABPA, hx of DVT/PE (remote, not on anticoagulation), HTN, HLD, PTSD came to the Emergency Room on 8/22/2021 for SOB and syncope in the setting of covid+, despite full vaccination with Pfizer Covid vaccine on 5/20/2021 and 6/10/2021. His wife then was diagnosed w/ covid approx 1 week prior and he tested positive on August 16th. He was feeling well until the last 3 days when he developed progressive dyspnea, cough w/ yellow sputum, and nausea. He was in his garage when he began to feel dizzy and passed out. His wife found him there, thought to be about 15 minutes later. He stated she did not notice any unusual jerking activity or incontinence. In the Emergency Dept, he was hypoxic requiring HFNC 45L/50%, tachycardic to 120, w/ cough & wheeze. CXR and CT PE indicative of COVID pneumonia. The patient was admitted to the Medical ICU from 8/22/21 to 10/14/21. He was intubated on 8/26/21. Unfortunately, he was out of the window for remdesivir and was not a candidate for baracitinib or monoclonal antibody due to concerns for infection. Patient had a prolonged hospital course while intubated complicated by vent dysynchrony, septic shock, and acute renal failure requiring tablo. He had a trach placed on 9/29/21 and has been off all ventilator support since 10/10/21. Tablo was stopped 9/17 and his renal function has since improved with just PRN Lasix (Serum Creatinine from 10/13 is 0.61). On 10/13, patient was transitioned to a cuffless trach and capping trials were started on 10/14. As far as antimicrobials, patient is currently on nystatin for oral thrush (10/13-preset) and cefepime for pseudomonas and klebsiella PNA (10/3-10/17). As far as feeding, patient passed a barium swallow study on 10/12. He still has NG tube feeds to supplement PO feeds. Once out of the ICU, the patient was stable and required minimal intervention. The patient completed his cefepime course with no evidence of reinfection. While on the ward, follow up chest x-rays were unchanged. White count similarly was within normal limits and stable. The patient was decanulated within the first 48 hours and has tolerated 2-3 liters of oxygen via nasal cannula well. He was dishcharge to an acute rehab facility on 10/26/21.
Age: 65.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Wheezing
Clinical narrative: Narrative:  Admission Date: Aug 22,2021 Discharge Date: Oct 26,2021 Condition of patient at discharge: Stable Disposition of Patient at Discharge: Acute Rehab Primary Diagnosis during Admission/Treatment: Acute respiratory failure in the context of COVID infection 64 YO MALE w/ Asthma-COPD overlap syndrome (ACOS), restrictive lung disease (FEV1 40%, TLC 50%), hx of ABPA, hx of DVT/PE (remote, not on anticoagulation), HTN, HLD, PTSD came to the Emergency Room on 8/22/2021 for SOB and syncope in the setting of covid+, despite full vaccination with Pfizer Covid vaccine on 5/20/2021 and 6/10/2021. His wife then was diagnosed w/ covid approx 1 week prior and he tested positive on August 16th. He was feeling well until the last 3 days when he developed progressive dyspnea, cough w/ yellow sputum, and nausea. He was in his garage when he began to feel dizzy and passed out. His wife found him there, thought to be about 15 minutes later. He stated she did not notice any unusual jerking activity or incontinence. In the Emergency Dept, he was hypoxic requiring HFNC 45L/50%, tachycardic to 120, w/ cough & wheeze. CXR and CT PE indicative of COVID pneumonia. The patient was admitted to the Medical ICU from 8/22/21 to 10/14/21. He was intubated on 8/26/21. Unfortunately, he was out of the window for remdesivir and was not a candidate for baracitinib or monoclonal antibody due to concerns for infection. Patient had a prolonged hospital course while intubated complicated by vent dysynchrony, septic shock, and acute renal failure requiring tablo. He had a trach placed on 9/29/21 and has been off all ventilator support since 10/10/21. Tablo was stopped 9/17 and his renal function has since improved with just PRN Lasix (Serum Creatinine from 10/13 is 0.61). On 10/13, patient was transitioned to a cuffless trach and capping trials were started on 10/14. As far as antimicrobials, patient is currently on nystatin for oral thrush (10/13-preset) and cefepime for pseudomonas and klebsiella PNA (10/3-10/17). As far as feeding, patient passed a barium swallow study on 10/12. He still has NG tube feeds to supplement PO feeds. Once out of the ICU, the patient was stable and required minimal intervention. The patient completed his cefepime course with no evidence of reinfection. While on the ward, follow up chest x-rays were unchanged. White count similarly was within normal limits and stable. The patient was decanulated within the first 48 hours and has tolerated 2-3 liters of oxygen via nasal cannula well. He was dishcharge to an acute rehab facility on 10/26/21.
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Death, Polyp
Clinical narrative: Narrative:  68yo male patient with metastatic prostate cancer,HLD,past HTN but on no BP meds,polyp-2023,osa,gerd,LBP,AAA,bilateral ureteral stents(changed out q6 months) died on 9/12/2021. He had received covid vaccines on 1/14/21 & 3/13/2021. Likely this death is not related to covid vaccines given patient's age, comorbidities, and long length of time between date of vaccines and date of death.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal pain, Death, General physical health deterioration, Shock, Swelling
Clinical narrative: Narrative:  Pt was a 66 YO male with h/o liver cirrhosis in the setting of Hepatitis B, polysubstance dependence, COPD, and psoriasis who presented to the agency ED due to a 2 week history of abdominal pain and swelling. Pt developed shock requiring pressor support and pt continued to decline despite treatment. Family decided to pursue comfort care and the pt passed comfortably in compliance with his wishes. Pt received the Moderna COVID-19 vaccine on 1/29/21, 3/1/21, and 10/7/21. There is no evidence that the COVID-19 vaccine contributed to his death.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Cough, Death, Dyspnoea, SARS-CoV-2 test negative
Clinical narrative: Narrative:  Pt was a 74 YO Male with PMH of major neurocognitive disorder with possible PD/LBD (last seen in cognitive clinic 2016), COPD on home O2 2Lpm, OSA on CPAP, CKD 4, recurrent UTIs, urinary retention, DMII w/neuropathy, paroxysmal A. Fib on apixaban, and HTN who presented to ED from another location on 10/5/21 with c/o cough and SOA. Pt was COVID-19 negative on admission. After discussion with family, pt requested to pursue hospice care. Comfort measures were initiated and the patient passed peacefully on 10/26/21. Death does not appear to be related to COVID-19 vaccine.
Age: 82.0
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Narrative:  82yo male patient with end stage renal disease died on 10/22/21 at inpt hospice care (non-agency facility). Pt had received covid vaccines on 5/6/21 & 6/3/21. Death is not related to covid vaccines.
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: Death, Fluid intake reduced, Haematemesis, Hepatic cirrhosis, Multiple organ dysfunction syndrome
Clinical narrative: Narrative:  Pt was a 55 YO male with PMH of alcohol associated cirrhosis c/b varices, HTN, GERD, and Aflutter presented to the ED on 10/8/21 with nausea/vomiting/hematemesis after stopping drinking for 2-3 days. Patient passed at 0452 on 10/24/21 from multisystem organ failure due to sepsis in the setting of decompensated cirrhosis. Pt received the Moderna COVID-19 vaccine on 2/6/21 and 3/1/21; it does not appear that death was related to the vaccine.
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: Nausea, Sepsis, Vomiting
Clinical narrative: Narrative:  Pt was a 55 YO male with PMH of alcohol associated cirrhosis c/b varices, HTN, GERD, and Aflutter presented to the ED on 10/8/21 with nausea/vomiting/hematemesis after stopping drinking for 2-3 days. Patient passed at 0452 on 10/24/21 from multisystem organ failure due to sepsis in the setting of decompensated cirrhosis. Pt received the Moderna COVID-19 vaccine on 2/6/21 and 3/1/21; it does not appear that death was related to the vaccine.
Age: 98.0
Sex: F
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Narrative:  Pt was a 97 YO female with PMH of DM2, HTN, diverticulosis, HLD, and hypothyroidism. Documented in records that she received a dose of the Pfizer COVID-19 vaccine; unclear which dose in series or exactly where it was administered. Death was reported by agency to another agency; no indication that the COVID-19 vaccine contributed to the death.
Age: 73.0
Sex: M
Vaccine: COVID19, FLUA4
Symptoms: Death, Intracranial aneurysm
Clinical narrative: Narrative: Patient with a history COPD, HTN, hyperlipidemia, diabetes, gout, and episode of syncope Sept 2020 (possible orthostatic hypotension). The day after COVID booster and influenza vaccine, patient was taken to an outside hospital by family at 6 am where he later died due to an brain aneurysm per report from the patient's son. The outside hospital did not think the brain aneurysm was related to vaccinations, per report from the patient's son.
Age: 90.0
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Narrative:  Pt was an 89 YO male with PMH of a fib, herpes sozter, ARF, CHF, arthralgia, CAD, angina, DJD, thrombocytopenia, anemia, HLD, and emphysema. Death was reported to agency by another agency. No details available. No evidence that COVID-19 vaccine contributed to the patient's death.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Atrial flutter, Condition aggravated, Death, Pancreatic carcinoma metastatic, Tachycardia
Clinical narrative: Narrative:  72y.o. MALE with a h/o Aflutter s/p ablation (08/21), metastatic pancreatic cancer, PE on Xarelto was admitted on 10/13/2021 for tachycardia likely recurrent Aflutter.On 10/14/2021 pt was transferred to inpatient hospice for Life-Limiting Illness: pancreatic cancer. Pt then died on 10/20/21 in the agency hospital inpatient hospice unit. Death was caused by: Metastatic Pancreatic Cancer Pt had received 3 covid vaccines on 3/18/21, 4/19/21 & 9/22/21. Death is not related to vaccines.
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Narrative:  78yo male patient with medical history of CA - Cancer of pancreas (SCT 363418001) CAD - Coronary artery disease (SCT 53741008) Ulcerative colitis (SCT 64766004) Hyperlipidemia (SCT 55822004) Dry eye syndrome (SCT 46152009) Leukopenia (SCT 419188005) Obstructive sleep apnea syndrome (SCT 78Hearing loss (SCT 15188001) Pt did not receive oncology care from agency. Pt died on 10/18/2021. No infor regarding circumstances of death given. Likely this death is not related to covid vaccines given patient's age, comorbidities, and long length of time between date of vaccines and date of death.
Age: 90.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, Death, Lung neoplasm malignant, Neoplasm malignant, Pleural effusion
Clinical narrative: Narrative:  90yo male patient died inpatient hospice on 10/22/21. Death was caused by: acute hypoxic respiratory failure r/t presumed lung primary malignancy with pneumonia and pleural effusion. Pt had received covid vaccines on 2/2/21 & 3/3/21. Death is not related to covid vaccines.
Age: 90.0
Sex: M
Vaccine: COVID19
Symptoms: Pneumonia
Clinical narrative: Narrative:  90yo male patient died inpatient hospice on 10/22/21. Death was caused by: acute hypoxic respiratory failure r/t presumed lung primary malignancy with pneumonia and pleural effusion. Pt had received covid vaccines on 2/2/21 & 3/3/21. Death is not related to covid vaccines.
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Facial paralysis, Lacunar stroke, Magnetic resonance imaging head abnormal, Muscular weakness
Clinical narrative: Narrative: Patient with no known past medical history, received 1st dose of Pfizer Covid vaccine on 10/20/21 and awoke on 10/21/21 with acute RUE and RLE weakness and facial droop, MRI confirmed acute lacunar stroke.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Narrative:  76yo male patient died at home in home hospice care on 10/25/2021.Pt had history of paroxysmal atrial fibrillation, obesity, dyslipidemia, kidney cancer and followed in this neurology clinic for Parkinson's disease, which he has had for about 20 years. Pt had received covid vaccines on 1/22/21 & 2/22/21. Likely this death is not related to covid vaccines given patient's age, comorbidities, and long length of time between date of vaccines and date of death.
Age: 88.0
Sex: M
Vaccine: COVID19
Symptoms: Actinic keratosis, Anxiety, Arteriosclerosis coronary artery, Arthritis, Bursitis
Clinical narrative: Narrative:  88yo male patient with the following problem list: R60.0 Localized edema (SCT 274724004) M13.862 Arthritis of left knee (SCT 1074851000119104) M13.861 Arthritis of right knee (SCT 1071861000119102) E78.00 Hyperlipidemia (SCT 55822004) M10.00 Gout (SCT 90560007) I25.89 Coronary arteriosclerosis (SCT 53741008) M70.21 Bursitis of olecranon of right elbow (SCT 314601000119108) E55.9 Vitamin D deficiency (SCT 34713006) R10.2 Rectal pain (SCT 77880009) K59.00 Constipation (SCT 14760008) F41.1 Anxiety (SCT 48694002) N14.0 Chronic gouty nephropathy (SCT 190829000) I10. Benign essential hypertension (SCT 1201005) M19.91 Osteoarthritis (SCT 396275006) 272.4 Hyperlipidemia (SCT 55822004) 716.60 Arthritis of Hip (ICD-9-CM 716.60) 799.9 agreement (ICD-9-CM 799.9) 274.9 Gout (ICD-9-CM 274.9) 401.9 Hypertension, Essential (ICD-9-CM 401.9) 414.9 Coronary Artery Disease (ICD-9-CM 414.9) 702.0 Actinic Keratosis (ICD-9-CM 702.0) 300.00 Anxiety (ICD-9-CM 300.00) Died on 10/15/2021 at non agency hospital after inpatient admission since 10/09/2021 when presented to ER for shortness of breath. No info about death given. pt had received covid vaccines on 1/29/21 & 2/22/21. Likely this death is not related to covid vaccines given patient's age, comorbidities, and long length of time between date of vaccines and date of death.
Age: 88.0
Sex: M
Vaccine: COVID19
Symptoms: Constipation, Coronary artery disease, Death, Dyspnoea, Essential hypertension
Clinical narrative: Narrative:  88yo male patient with the following problem list: R60.0 Localized edema (SCT 274724004) M13.862 Arthritis of left knee (SCT 1074851000119104) M13.861 Arthritis of right knee (SCT 1071861000119102) E78.00 Hyperlipidemia (SCT 55822004) M10.00 Gout (SCT 90560007) I25.89 Coronary arteriosclerosis (SCT 53741008) M70.21 Bursitis of olecranon of right elbow (SCT 314601000119108) E55.9 Vitamin D deficiency (SCT 34713006) R10.2 Rectal pain (SCT 77880009) K59.00 Constipation (SCT 14760008) F41.1 Anxiety (SCT 48694002) N14.0 Chronic gouty nephropathy (SCT 190829000) I10. Benign essential hypertension (SCT 1201005) M19.91 Osteoarthritis (SCT 396275006) 272.4 Hyperlipidemia (SCT 55822004) 716.60 Arthritis of Hip (ICD-9-CM 716.60) 799.9 agreement (ICD-9-CM 799.9) 274.9 Gout (ICD-9-CM 274.9) 401.9 Hypertension, Essential (ICD-9-CM 401.9) 414.9 Coronary Artery Disease (ICD-9-CM 414.9) 702.0 Actinic Keratosis (ICD-9-CM 702.0) 300.00 Anxiety (ICD-9-CM 300.00) Died on 10/15/2021 at non agency hospital after inpatient admission since 10/09/2021 when presented to ER for shortness of breath. No info about death given. pt had received covid vaccines on 1/29/21 & 2/22/21. Likely this death is not related to covid vaccines given patient's age, comorbidities, and long length of time between date of vaccines and date of death.
Age: 88.0
Sex: M
Vaccine: COVID19
Symptoms: Gout, Hyperlipidaemia, Localised oedema, Osteoarthritis, Proctalgia
Clinical narrative: Narrative:  88yo male patient with the following problem list: R60.0 Localized edema (SCT 274724004) M13.862 Arthritis of left knee (SCT 1074851000119104) M13.861 Arthritis of right knee (SCT 1071861000119102) E78.00 Hyperlipidemia (SCT 55822004) M10.00 Gout (SCT 90560007) I25.89 Coronary arteriosclerosis (SCT 53741008) M70.21 Bursitis of olecranon of right elbow (SCT 314601000119108) E55.9 Vitamin D deficiency (SCT 34713006) R10.2 Rectal pain (SCT 77880009) K59.00 Constipation (SCT 14760008) F41.1 Anxiety (SCT 48694002) N14.0 Chronic gouty nephropathy (SCT 190829000) I10. Benign essential hypertension (SCT 1201005) M19.91 Osteoarthritis (SCT 396275006) 272.4 Hyperlipidemia (SCT 55822004) 716.60 Arthritis of Hip (ICD-9-CM 716.60) 799.9 agreement (ICD-9-CM 799.9) 274.9 Gout (ICD-9-CM 274.9) 401.9 Hypertension, Essential (ICD-9-CM 401.9) 414.9 Coronary Artery Disease (ICD-9-CM 414.9) 702.0 Actinic Keratosis (ICD-9-CM 702.0) 300.00 Anxiety (ICD-9-CM 300.00) Died on 10/15/2021 at non agency hospital after inpatient admission since 10/09/2021 when presented to ER for shortness of breath. No info about death given. pt had received covid vaccines on 1/29/21 & 2/22/21. Likely this death is not related to covid vaccines given patient's age, comorbidities, and long length of time between date of vaccines and date of death.
Age: 88.0
Sex: M
Vaccine: COVID19
Symptoms: Urate nephropathy, Vitamin D deficiency
Clinical narrative: Narrative:  88yo male patient with the following problem list: R60.0 Localized edema (SCT 274724004) M13.862 Arthritis of left knee (SCT 1074851000119104) M13.861 Arthritis of right knee (SCT 1071861000119102) E78.00 Hyperlipidemia (SCT 55822004) M10.00 Gout (SCT 90560007) I25.89 Coronary arteriosclerosis (SCT 53741008) M70.21 Bursitis of olecranon of right elbow (SCT 314601000119108) E55.9 Vitamin D deficiency (SCT 34713006) R10.2 Rectal pain (SCT 77880009) K59.00 Constipation (SCT 14760008) F41.1 Anxiety (SCT 48694002) N14.0 Chronic gouty nephropathy (SCT 190829000) I10. Benign essential hypertension (SCT 1201005) M19.91 Osteoarthritis (SCT 396275006) 272.4 Hyperlipidemia (SCT 55822004) 716.60 Arthritis of Hip (ICD-9-CM 716.60) 799.9 agreement (ICD-9-CM 799.9) 274.9 Gout (ICD-9-CM 274.9) 401.9 Hypertension, Essential (ICD-9-CM 401.9) 414.9 Coronary Artery Disease (ICD-9-CM 414.9) 702.0 Actinic Keratosis (ICD-9-CM 702.0) 300.00 Anxiety (ICD-9-CM 300.00) Died on 10/15/2021 at non agency hospital after inpatient admission since 10/09/2021 when presented to ER for shortness of breath. No info about death given. pt had received covid vaccines on 1/29/21 & 2/22/21. Likely this death is not related to covid vaccines given patient's age, comorbidities, and long length of time between date of vaccines and date of death.
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: Acquired diaphragmatic eventration, Ageusia, Anosmia, Atelectasis, Blood bicarbonate decreased
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 06/02, Pfizer, dose #1 07/02, Pfizer, dose #2 07/07 COVID swab, result: NOT detected 07/13 CXR impression: 1. Mild left basilar atelectasis and slight elevation of the left hemidiaphragm. 07/19 ABG result: i-pH 7.43, i-PCO2 31.7, iPO2 73, i-HCO3 20.8 07/16 pt admitted to medicine cc: dizziness and gait dx: CVA LOS: 24 days 07/21 ABG result: i-pH 7.40, i-PCO2 31.9, iPO2 69, i-HCO3 19.8 07/21 amonia 37 07/25 CXR Impression: Interval extubation with slightly improved, increased lung volumes. 2. Patchy bibasilar parenchymal changes in the lungs. Findings could represent atelectasis or pneumonia. These are felt likely unchanged when allowing for the improved aeration on this exam. 08/03 PO4 results: 6.1 08/03 pt cc: loss of taste or smell, rhinorrhea, dyspnea, exposure: unknown 08/04 PT/INR 22.6/ 2.02 08/05 PT/INR 20.1/ 1.79 08/06 PT/INR 20.3/ 1.81 08/06 COVID swab, result: NOT detected 08/31 COVID swab, result: detected 10/16 pt deceased
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: Blood gases abnormal, Blood pH normal, COVID-19, Chest X-ray abnormal, Death
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 06/02, Pfizer, dose #1 07/02, Pfizer, dose #2 07/07 COVID swab, result: NOT detected 07/13 CXR impression: 1. Mild left basilar atelectasis and slight elevation of the left hemidiaphragm. 07/19 ABG result: i-pH 7.43, i-PCO2 31.7, iPO2 73, i-HCO3 20.8 07/16 pt admitted to medicine cc: dizziness and gait dx: CVA LOS: 24 days 07/21 ABG result: i-pH 7.40, i-PCO2 31.9, iPO2 69, i-HCO3 19.8 07/21 amonia 37 07/25 CXR Impression: Interval extubation with slightly improved, increased lung volumes. 2. Patchy bibasilar parenchymal changes in the lungs. Findings could represent atelectasis or pneumonia. These are felt likely unchanged when allowing for the improved aeration on this exam. 08/03 PO4 results: 6.1 08/03 pt cc: loss of taste or smell, rhinorrhea, dyspnea, exposure: unknown 08/04 PT/INR 22.6/ 2.02 08/05 PT/INR 20.1/ 1.79 08/06 PT/INR 20.3/ 1.81 08/06 COVID swab, result: NOT detected 08/31 COVID swab, result: detected 10/16 pt deceased
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Dyspnoea, Gait disturbance, International normalised ratio increased, PCO2 decreased
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 06/02, Pfizer, dose #1 07/02, Pfizer, dose #2 07/07 COVID swab, result: NOT detected 07/13 CXR impression: 1. Mild left basilar atelectasis and slight elevation of the left hemidiaphragm. 07/19 ABG result: i-pH 7.43, i-PCO2 31.7, iPO2 73, i-HCO3 20.8 07/16 pt admitted to medicine cc: dizziness and gait dx: CVA LOS: 24 days 07/21 ABG result: i-pH 7.40, i-PCO2 31.9, iPO2 69, i-HCO3 19.8 07/21 amonia 37 07/25 CXR Impression: Interval extubation with slightly improved, increased lung volumes. 2. Patchy bibasilar parenchymal changes in the lungs. Findings could represent atelectasis or pneumonia. These are felt likely unchanged when allowing for the improved aeration on this exam. 08/03 PO4 results: 6.1 08/03 pt cc: loss of taste or smell, rhinorrhea, dyspnea, exposure: unknown 08/04 PT/INR 22.6/ 2.02 08/05 PT/INR 20.1/ 1.79 08/06 PT/INR 20.3/ 1.81 08/06 COVID swab, result: NOT detected 08/31 COVID swab, result: detected 10/16 pt deceased
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: PO2 decreased, Prothrombin time prolonged, Rhinorrhoea, SARS-CoV-2 test positive
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 06/02, Pfizer, dose #1 07/02, Pfizer, dose #2 07/07 COVID swab, result: NOT detected 07/13 CXR impression: 1. Mild left basilar atelectasis and slight elevation of the left hemidiaphragm. 07/19 ABG result: i-pH 7.43, i-PCO2 31.7, iPO2 73, i-HCO3 20.8 07/16 pt admitted to medicine cc: dizziness and gait dx: CVA LOS: 24 days 07/21 ABG result: i-pH 7.40, i-PCO2 31.9, iPO2 69, i-HCO3 19.8 07/21 amonia 37 07/25 CXR Impression: Interval extubation with slightly improved, increased lung volumes. 2. Patchy bibasilar parenchymal changes in the lungs. Findings could represent atelectasis or pneumonia. These are felt likely unchanged when allowing for the improved aeration on this exam. 08/03 PO4 results: 6.1 08/03 pt cc: loss of taste or smell, rhinorrhea, dyspnea, exposure: unknown 08/04 PT/INR 22.6/ 2.02 08/05 PT/INR 20.1/ 1.79 08/06 PT/INR 20.3/ 1.81 08/06 COVID swab, result: NOT detected 08/31 COVID swab, result: detected 10/16 pt deceased
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Death, Hypotension, Syncope
Clinical narrative: Narrative: 66yo male patient died at outside hospital on 10/15/2021 after had self-presented to community emergency facility on 10/13/2021 for syncopal episode at home and hypotension. No other info available regarding circumstances of pt's death. Medical history:PROBLEM LIST: Sleep disorder (SCT 39898005) CVA - Cerebrovascular accident (SCT 230690007) Viral hepatitis C (SCT 50711007) Hypercalcemia (SCT 66931009) Impaired Fasting Glucose (ICD-9-CM 790.2Hepatitis C antibody test positive (SCT 314706002) Other and unspecified alcohol dependenceCocaine dependence (SCT 31956009) Psychoactive substance-induced organic mSuicidal (SCT 267073005) Alcohol abuse (SCT 15167005) Cocaine abuse (SCT 78267003) Hyperkalemia (ICD-9-CM 276.7) Hyperlipidemia (SCT 55822004) Hematuria (SCT 34436003) Benign essential hypertension (SCT 1201005) Hyperlipidemia (SCT 55822004) Liver function tests abnormal (SCT 166603001) Health Maintenance (ICD-9-CM V65.9) Pneumonia (ICD-9-CM 486.) Tobacco use (SCT 110483000) Pt had received covid vaccines at agency hospital on 3/19/21 & 4/11/21. Likely this death is not related to covid vaccines given patient's age, comorbidities, and long length of time between date of vaccines and date of death.
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Narrative:  63yo patient with hx of morbid obesity, HTN, COPD, sleep apnea, Osteoarthritis, GI reflux & anxiety Dx died on 9/27/2021. Pt had received one covid vaccine on 5/10/21 from the agency. Pt resided in community care nursing facility. Likely pt's death is not related to covid vaccine given pt's medical history, and length of time between date of death & date of vaccine administration.
Age: 89.0
Sex: M
Vaccine: COVID19
Symptoms: Death, Fall, Joint injury, Limb injury
Clinical narrative: Narrative:  89yo male patient died on 10/2/2021 at Medical Center due to complications after a fall and injuries to left hip & arm/shoulder. Pt had received covid vaccines on 2/23/21 & 3/23/21. Pt also had hx of end stage renal disease, CHF, HTN, DM, anemia, basal cell carcinoma of nose. Likely this death is not related to covid vaccines given patient's age, comorbidities, and long length of time between date of vaccines and date of death.
Age: 88.0
Sex: M
Vaccine: COVID19
Symptoms: Anaemia, Chronic kidney disease, Coronary artery disease, Deafness, Death
Clinical narrative: Narrative:  87yo male patient with the following: PROBLEM LIST: Diabetes HTN CAD Anemia CKD Hearing loss MEDICAL HISTORY: Squamous cell carcinoma of hand Basal cell carcinoma of skin TIA Died on 10/2/2021 at non-agency hospital. No info given about pt's death. Pt did receive covid vaccines at non-agency hospital on 1/15/21 & 2/12/21. Likely this death is not related to covid vaccines given patient's age, comorbidities, and long length of time between date of vaccines and date of death.
Age: 88.0
Sex: M
Vaccine: COVID19
Symptoms: Diabetes mellitus, Hypertension
Clinical narrative: Narrative:  87yo male patient with the following: PROBLEM LIST: Diabetes HTN CAD Anemia CKD Hearing loss MEDICAL HISTORY: Squamous cell carcinoma of hand Basal cell carcinoma of skin TIA Died on 10/2/2021 at non-agency hospital. No info given about pt's death. Pt did receive covid vaccines at non-agency hospital on 1/15/21 & 2/12/21. Likely this death is not related to covid vaccines given patient's age, comorbidities, and long length of time between date of vaccines and date of death.
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Narrative:  78 yo male with PMHx of GBM (multifocal glioblastoma- brain cancer), DM, HTN, h/o pacemaker, COPD, HTN, OA, dementia, retinopathy, venous insufficiency, h/o asthma, OSA, h/o anxiety, GERD, who died on 10:21/21 at home in home hospice care. Pt had received 3 covid vaccines on 1/20/21, 2/26/21, & 8/24/21. Death is not related to vaccines.
Age: 82.0
Sex: M
Vaccine: COVID19
Symptoms: Angiogram pulmonary abnormal, Blood fibrinogen normal, Bronchostenosis, COVID-19, COVID-19 pneumonia
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 02/21, Pfizer, dose #1 03/10, Pfizer, dose #2 08/31 pt cc: cough, diarrhea, dyspnea exposure: unknown 08/31 COVID swab, result: detected 08/31 SARS-COV-2 LINEAGE AY.25 08/31 SARS-COV-2 CLADE 21 J DELTA 09/01 pt admit to Medicine cc: cough and leg edema dx: covid 19 pneumonia LOS: 10 days 09/01 CXR impression: Bilateral airspace disease. Correlate clinically for pneumonia including viral/atypical etiology and follow-up to resolution 09/01 US extremity impression: 1. Right lower extremity: Findings suggestive of a subtle nonocclusive thrombus in the deep femoral vein. 2. Left lower extremity: Mild mural irregularity and echogenicity focally in the mid/distal femoral vein perhaps from a chronic nonocclusive thrombus 09/01 CTA PE impression: 1. No evidence of pulmonary embolism or dissection. 2. Patchy peripheral groundglass and consolidative opacities which can be seen with a history of Covid. 3. Stenosis of the left lung bronchi which is likely due to position however recommend contrast enhanced CT after resolution of acute infection. 4. Severe degenerative changes of the spine status post cervical and lumbar. Bones are diffusely osteopenic. Multiple compression fractures. The critical result of follow-up CT for bronchial stenosis was communicated to Dr. on 9/1/2021 at 21:07 with read-back verification. 09/01 PROCALCITONIN results: <0.05 09/01 DDIMER result: 0.74 09/02 CXR impression: Similar-appearing retrocardiac and right infrahilar opacities suspicious for pneumonia. 09/02 ESR result: 10 09/02 Fibrinogen result: 261 09/02 DDIMER result: 0.79 09/03 ESR result: 9 09/03 Fibrinogen result: 240 09/03 DDIMER result: 0.52 09/04 ESR result: 11 09/04 Fibrinogen result: 200 09/04 DDIMER result: 0.78 09/05 ESR result: 5 09/05 Fibrinogen result: 207 09/05 DDIMER result: 0.90 09/06 ESR result: 9 09/06 Fibrinogen result: 228 09/06 DDIMER result: 1.03 09/07 ESR result: 3 09/07 Fibrinogen result: 245 09/07 DDIMER result: 0.69 09/08 ESR result: 9 09/08 Fibrinogen result: 264 09/08 DDIMER result: 0.97 09/10 clinically resolved
Age: 82.0
Sex: M
Vaccine: COVID19
Symptoms: Chest X-ray abnormal, Compression fracture, Cough, Deep vein thrombosis, Diarrhoea
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 02/21, Pfizer, dose #1 03/10, Pfizer, dose #2 08/31 pt cc: cough, diarrhea, dyspnea exposure: unknown 08/31 COVID swab, result: detected 08/31 SARS-COV-2 LINEAGE AY.25 08/31 SARS-COV-2 CLADE 21 J DELTA 09/01 pt admit to Medicine cc: cough and leg edema dx: covid 19 pneumonia LOS: 10 days 09/01 CXR impression: Bilateral airspace disease. Correlate clinically for pneumonia including viral/atypical etiology and follow-up to resolution 09/01 US extremity impression: 1. Right lower extremity: Findings suggestive of a subtle nonocclusive thrombus in the deep femoral vein. 2. Left lower extremity: Mild mural irregularity and echogenicity focally in the mid/distal femoral vein perhaps from a chronic nonocclusive thrombus 09/01 CTA PE impression: 1. No evidence of pulmonary embolism or dissection. 2. Patchy peripheral groundglass and consolidative opacities which can be seen with a history of Covid. 3. Stenosis of the left lung bronchi which is likely due to position however recommend contrast enhanced CT after resolution of acute infection. 4. Severe degenerative changes of the spine status post cervical and lumbar. Bones are diffusely osteopenic. Multiple compression fractures. The critical result of follow-up CT for bronchial stenosis was communicated to Dr. on 9/1/2021 at 21:07 with read-back verification. 09/01 PROCALCITONIN results: <0.05 09/01 DDIMER result: 0.74 09/02 CXR impression: Similar-appearing retrocardiac and right infrahilar opacities suspicious for pneumonia. 09/02 ESR result: 10 09/02 Fibrinogen result: 261 09/02 DDIMER result: 0.79 09/03 ESR result: 9 09/03 Fibrinogen result: 240 09/03 DDIMER result: 0.52 09/04 ESR result: 11 09/04 Fibrinogen result: 200 09/04 DDIMER result: 0.78 09/05 ESR result: 5 09/05 Fibrinogen result: 207 09/05 DDIMER result: 0.90 09/06 ESR result: 9 09/06 Fibrinogen result: 228 09/06 DDIMER result: 1.03 09/07 ESR result: 3 09/07 Fibrinogen result: 245 09/07 DDIMER result: 0.69 09/08 ESR result: 9 09/08 Fibrinogen result: 264 09/08 DDIMER result: 0.97 09/10 clinically resolved
Age: 82.0
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea, Fibrin D dimer, Lung opacity, Oedema peripheral, Osteopenia
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 02/21, Pfizer, dose #1 03/10, Pfizer, dose #2 08/31 pt cc: cough, diarrhea, dyspnea exposure: unknown 08/31 COVID swab, result: detected 08/31 SARS-COV-2 LINEAGE AY.25 08/31 SARS-COV-2 CLADE 21 J DELTA 09/01 pt admit to Medicine cc: cough and leg edema dx: covid 19 pneumonia LOS: 10 days 09/01 CXR impression: Bilateral airspace disease. Correlate clinically for pneumonia including viral/atypical etiology and follow-up to resolution 09/01 US extremity impression: 1. Right lower extremity: Findings suggestive of a subtle nonocclusive thrombus in the deep femoral vein. 2. Left lower extremity: Mild mural irregularity and echogenicity focally in the mid/distal femoral vein perhaps from a chronic nonocclusive thrombus 09/01 CTA PE impression: 1. No evidence of pulmonary embolism or dissection. 2. Patchy peripheral groundglass and consolidative opacities which can be seen with a history of Covid. 3. Stenosis of the left lung bronchi which is likely due to position however recommend contrast enhanced CT after resolution of acute infection. 4. Severe degenerative changes of the spine status post cervical and lumbar. Bones are diffusely osteopenic. Multiple compression fractures. The critical result of follow-up CT for bronchial stenosis was communicated to Dr. on 9/1/2021 at 21:07 with read-back verification. 09/01 PROCALCITONIN results: <0.05 09/01 DDIMER result: 0.74 09/02 CXR impression: Similar-appearing retrocardiac and right infrahilar opacities suspicious for pneumonia. 09/02 ESR result: 10 09/02 Fibrinogen result: 261 09/02 DDIMER result: 0.79 09/03 ESR result: 9 09/03 Fibrinogen result: 240 09/03 DDIMER result: 0.52 09/04 ESR result: 11 09/04 Fibrinogen result: 200 09/04 DDIMER result: 0.78 09/05 ESR result: 5 09/05 Fibrinogen result: 207 09/05 DDIMER result: 0.90 09/06 ESR result: 9 09/06 Fibrinogen result: 228 09/06 DDIMER result: 1.03 09/07 ESR result: 3 09/07 Fibrinogen result: 245 09/07 DDIMER result: 0.69 09/08 ESR result: 9 09/08 Fibrinogen result: 264 09/08 DDIMER result: 0.97 09/10 clinically resolved
Age: 82.0
Sex: M
Vaccine: COVID19
Symptoms: Procalcitonin normal, Pulmonary infarction, Red blood cell sedimentation rate normal, SARS-CoV-2 test positive, Spinal osteoarthritis
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 02/21, Pfizer, dose #1 03/10, Pfizer, dose #2 08/31 pt cc: cough, diarrhea, dyspnea exposure: unknown 08/31 COVID swab, result: detected 08/31 SARS-COV-2 LINEAGE AY.25 08/31 SARS-COV-2 CLADE 21 J DELTA 09/01 pt admit to Medicine cc: cough and leg edema dx: covid 19 pneumonia LOS: 10 days 09/01 CXR impression: Bilateral airspace disease. Correlate clinically for pneumonia including viral/atypical etiology and follow-up to resolution 09/01 US extremity impression: 1. Right lower extremity: Findings suggestive of a subtle nonocclusive thrombus in the deep femoral vein. 2. Left lower extremity: Mild mural irregularity and echogenicity focally in the mid/distal femoral vein perhaps from a chronic nonocclusive thrombus 09/01 CTA PE impression: 1. No evidence of pulmonary embolism or dissection. 2. Patchy peripheral groundglass and consolidative opacities which can be seen with a history of Covid. 3. Stenosis of the left lung bronchi which is likely due to position however recommend contrast enhanced CT after resolution of acute infection. 4. Severe degenerative changes of the spine status post cervical and lumbar. Bones are diffusely osteopenic. Multiple compression fractures. The critical result of follow-up CT for bronchial stenosis was communicated to Dr. on 9/1/2021 at 21:07 with read-back verification. 09/01 PROCALCITONIN results: <0.05 09/01 DDIMER result: 0.74 09/02 CXR impression: Similar-appearing retrocardiac and right infrahilar opacities suspicious for pneumonia. 09/02 ESR result: 10 09/02 Fibrinogen result: 261 09/02 DDIMER result: 0.79 09/03 ESR result: 9 09/03 Fibrinogen result: 240 09/03 DDIMER result: 0.52 09/04 ESR result: 11 09/04 Fibrinogen result: 200 09/04 DDIMER result: 0.78 09/05 ESR result: 5 09/05 Fibrinogen result: 207 09/05 DDIMER result: 0.90 09/06 ESR result: 9 09/06 Fibrinogen result: 228 09/06 DDIMER result: 1.03 09/07 ESR result: 3 09/07 Fibrinogen result: 245 09/07 DDIMER result: 0.69 09/08 ESR result: 9 09/08 Fibrinogen result: 264 09/08 DDIMER result: 0.97 09/10 clinically resolved